The Link Between Heart Disease and Dementia
AI Overview: Cardiovascular health and brain health are closely connected. High blood pressure, diabetes, smoking, physical inactivity, obesity and abnormal cholesterol can affect both cardiovascular and cognitive risk. Heart conditions including coronary heart disease, atrial fibrillation and heart failure are also associated with cognitive impairment. Protecting vascular health throughout adulthood is an important part of reducing long-term risk to the brain.
For years, heart disease and dementia were discussed as though they belonged to different parts of medicine. We now have a much better understanding of how closely cardiovascular health and brain health overlap.
The brain receives about one-fifth of the body's blood supply and depends on healthy arteries, small blood vessels and reliable cardiac output throughout life. Hypertension, diabetes, smoking, atherosclerosis and other cardiovascular problems can gradually damage that system long before a person notices a change in memory.
This does not mean that heart disease and Alzheimer's disease are the same condition. They are not. It does mean that many of the health problems we spend decades trying to prevent in cardiology also have consequences for the aging brain.
One-Minute Read
The connection between heart disease and dementia is partly vascular and partly metabolic. The brain relies on continuous blood flow through arteries and an enormous network of small vessels. Years of high blood pressure, diabetes, smoking and atherosclerosis can injure that circulation and increase the likelihood of stroke, cerebral small-vessel disease and cognitive impairment.
Several heart conditions are also associated with cognition. Atrial fibrillation increases the risk of stroke and has been linked with cognitive decline even in research that accounts for recognized strokes. Heart failure can reduce cerebral blood flow and commonly occurs alongside vascular and metabolic disease. Coronary heart disease is associated with a higher risk of dementia as well.
Alzheimer's disease remains a distinct neurodegenerative disease involving amyloid, tau and other biological changes. In older adults, however, Alzheimer's pathology often exists alongside vascular disease in the brain. Dementia frequently reflects more than one disease process.
Blood pressure control, physical activity, diabetes prevention and treatment, smoking cessation, lipid management, healthy body composition and attention to sleep are therefore relevant to both cardiovascular and cognitive health.
Preventing a heart attack and protecting the brain are not separate health projects. Much of the work begins with the same physiology.
The Brain Depends on the Cardiovascular System
Brain tissue has a high demand for oxygen and glucose and very little tolerance for interruption in its blood supply. Large arteries carry blood toward the brain, while increasingly smaller vessels deliver it to the tissue where neurons are working.
Damage can occur at several levels. A major artery can become blocked and cause an obvious stroke. Smaller vessels can develop disease that appears on brain imaging as white-matter changes, small infarcts or microbleeds. Some injuries produce no dramatic event at the time and accumulate gradually over many years.
Vascular injury often affects processing speed, attention and executive function, although the clinical pattern varies widely from one person to another.
Most Dementia Is More Complicated Than a Single Diagnosis
Alzheimer's disease is the most common cause of dementia and has its own characteristic biology, including amyloid plaques and tau pathology.
Autopsy and biomarker research has also shown that older adults frequently have more than one form of brain pathology. Alzheimer's changes commonly occur alongside cerebrovascular disease, Lewy body pathology or other age-related changes.
This is generally described as mixed dementia or mixed pathology.
For the patient sitting in front of us, genetics and amyloid biology may be part of the future risk while decades of blood-pressure exposure, glucose regulation, smoking, physical activity and cardiovascular disease influence the same brain from another direction.
High Blood Pressure Has One of the Clearest Connections
Hypertension exposes arteries and small vessels to increased pressure year after year. In the brain, chronic hypertension is associated with stroke, cerebral small-vessel disease, white-matter injury and cognitive decline.
The cardiovascular consequences are equally familiar: coronary disease, heart failure, atrial fibrillation, kidney disease and stroke.
Current U.S. hypertension guidelines now include prevention of cognitive impairment and dementia among the reasons to treat high blood pressure. For most adults with hypertension, the general treatment goal is below 130/80 mm Hg, with individualization when age, frailty, medication tolerance or other clinical factors require it.
We cover this in more detail in Hypertension and Longevity: Why Blood Pressure Is About Much More Than Your Heart.
Atrial Fibrillation Reaches Beyond Stroke Risk
Atrial fibrillation, or AF, is an abnormal heart rhythm that becomes increasingly common with age. One of its major complications is ischemic stroke, which occurs when a blood clot travels to the brain.
The relationship between AF and cognition appears to extend beyond clinically recognized stroke. Large studies and meta-analyses have consistently found higher rates of cognitive impairment and dementia among people with atrial fibrillation.
Researchers are examining several possible contributors, including small or silent embolic events, cerebral microbleeds, altered blood flow, inflammation and the cardiovascular risk factors that commonly accompany AF.
Appropriate anticoagulation when indicated remains central to stroke prevention. Blood pressure, sleep apnea, alcohol, weight and other cardiovascular factors also deserve attention because they can influence both AF and the broader vascular environment.
Heart Failure Can Affect the Brain
Heart failure develops when the heart cannot pump or fill well enough to meet the body's needs without abnormal pressures or other physiologic compensation.
Cognitive difficulties are common in people living with heart failure. The American Heart Association's 2024 scientific statement reviewing cardiac contributions to brain health cited research estimating cognitive impairment in roughly 43% of patients with heart failure, although estimates vary considerably among studies and populations.
Reduced cerebral perfusion may contribute, along with inflammation, vascular disease, previous infarction, kidney dysfunction and the other medical conditions that frequently accompany heart failure.
Cognitive problems can also make heart failure harder to manage because treatment often requires several medications, attention to symptoms, dietary changes and regular monitoring.
Coronary Heart Disease and Cognitive Health
Coronary heart disease reflects atherosclerosis in the arteries supplying the heart. Atherosclerosis is a systemic disease, so coronary disease often occurs in people who also have vascular disease elsewhere.
A large systematic review summarized by the American Heart Association found that people with a history of coronary heart disease had a 27% higher relative risk of dementia than those without coronary heart disease.
This does not mean that a coronary calcium score or coronary CT angiogram can predict whether someone will develop dementia. Coronary imaging evaluates the coronary arteries and answers cardiovascular questions. It does not examine the cerebral circulation or diagnose Alzheimer's disease.
The value of finding coronary disease early is that it gives us clinically relevant information about cardiovascular risk at a time when treatment may reduce the chance of myocardial infarction, stroke and other vascular complications.
Cholesterol Belongs in the Brain-Health Discussion
Cholesterol and dementia have often been discussed in confusing ways because relationships observed late in life can differ from exposures occurring decades earlier.
The 2024 Lancet Commission on dementia prevention added high LDL cholesterol in midlife to its list of potentially modifiable dementia risk factors.
That finding fits with the larger vascular picture. Prolonged exposure to atherogenic lipoproteins contributes to atherosclerosis, while vascular disease and stroke contribute to cognitive impairment.
Lipid treatment should still be based on established cardiovascular indications rather than the promise that lowering LDL will prevent Alzheimer's disease. At present, cholesterol management is best understood as part of comprehensive cardiovascular and vascular risk reduction.
Diabetes, Visceral Fat and Metabolic Health
Type 2 diabetes is associated with both cardiovascular disease and dementia. Insulin resistance often precedes diabetes by years and commonly occurs with visceral adiposity, hypertension, elevated triglycerides, fatty liver disease and sleep apnea.
Each of these conditions can influence vascular health.
The brain effects of metabolic disease are probably the result of several overlapping processes, including vascular injury, inflammation, glucose abnormalities and other systemic changes. Researchers are also studying insulin signaling within the brain, although “brain insulin resistance” is not a routine clinical diagnosis.
Read How Insulin Resistance Affects the Brain.
Sleep Apnea Connects the Same Systems
Obstructive sleep apnea repeatedly interrupts breathing during sleep and is associated with hypertension, atrial fibrillation, insulin resistance and other cardiovascular problems.
Untreated OSA can produce intermittent reductions in oxygen, sleep fragmentation and sympathetic nervous system activation. Sleep disorders have also been associated with adverse brain-health outcomes, including stroke and cognitive impairment.
Sleep apnea deserves particular consideration when someone has resistant hypertension, atrial fibrillation, significant daytime fatigue, loud snoring or witnessed pauses in breathing.
Read Sleep Apnea and Brain Health.
The Major Risk Factors Travel Together
The 2024 Lancet Commission estimated that addressing 14 potentially modifiable factors across the lifespan could prevent or delay a substantial proportion of dementia cases at the population level.
Several of those factors are familiar from preventive cardiology:
- Hypertension
- High LDL cholesterol in midlife
- Diabetes
- Obesity
- Physical inactivity
- Smoking
- Excessive alcohol use
Other dementia risk factors, including hearing loss, depression, social isolation, traumatic brain injury, air pollution and untreated vision loss, remind us that cardiovascular health is only one part of dementia prevention.
No responsible prevention plan can promise that controlling cardiovascular risk will prevent Alzheimer's disease. It can reduce several established risks for stroke, vascular brain injury and cardiovascular disease while addressing factors consistently associated with cognitive decline.
Why Midlife Deserves More Attention
Many of the exposures associated with later cognitive decline begin decades before memory becomes a concern.
A person may spend their 40s and 50s with moderately elevated blood pressure, increasing visceral fat, untreated sleep apnea, rising glucose and progressive atherosclerosis while feeling perfectly well.
By the time cardiovascular or cognitive symptoms appear, those exposures may have been present for twenty or thirty years.
This is why preventive care during midlife carries so much weight. We have time to address blood pressure, smoking, activity, weight, diabetes and lipid exposure before many of their clinical consequences appear.
What Preventive Cardiology Can and Cannot Tell Us
Preventive cardiology can identify cardiovascular risk that routine symptom-based care may miss. Depending on the patient, evaluation may include blood pressure, ApoB, Lipoprotein(a), glucose and metabolic markers, body composition, carotid assessment, coronary calcium or coronary CT angiography.
Those tests evaluate cardiovascular and metabolic health. They should not be presented as dementia tests.
A coronary CT angiogram may identify noncalcified and calcified coronary plaque. A DEXA scan may identify visceral adiposity. Blood testing may uncover diabetes or atherogenic lipoprotein exposure. Home blood-pressure readings may reveal previously unrecognized hypertension. Each finding has clinical value without requiring us to claim that it predicts Alzheimer's disease.
How We Approach Heart and Brain Health at HormoneSynergy®
Our preventive longevity work brings cardiovascular, metabolic and cognitive health into the same clinical discussion because the risk factors frequently overlap.
Depending on the patient, that may include:
- Blood-pressure assessment and home monitoring
- ApoB, Lipoprotein(a) and other cardiovascular risk markers
- Glucose and metabolic evaluation
- DEXA body composition and visceral-fat assessment
- Sleep and possible sleep-apnea evaluation
- Exercise, strength and muscle preservation
- Cognitive assessment when clinically appropriate
- Vascular and coronary imaging when it answers a cardiovascular question
We are interested in what these findings show together. Someone with hypertension, visceral adiposity, sleep apnea and early atherosclerosis has a different prevention picture from someone whose cardiovascular and metabolic measures remain favorable.
The work is still individualized. Genetics, age, family history, existing disease, medication tolerance and personal priorities remain part of the decision-making process.
Related Reading
Preventive Cardiology at HormoneSynergy®
Cardiovascular disease often develops for years before it produces symptoms. HormoneSynergy® uses cardiovascular risk assessment, metabolic evaluation and selected imaging to help identify disease and risk earlier and place those findings into the patient's broader longevity plan.
Selected References
- Testai FD, Gorelick PB, Chuang P-Y, et al. Cardiac Contributions to Brain Health: A Scientific Statement From the American Heart Association. Stroke. 2024. doi:10.1161/STR.0000000000000476.
- Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404(10452):572-628. doi:10.1016/S0140-6736(24)01296-0.
- Jones DW, et al. 2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Circulation. 2025.
- National Institute on Aging. Alzheimer's Disease and Related Dementias: Risk Factors, Genetics, Disease Mechanisms and Mixed Dementias.
This article is for educational purposes and is not intended to diagnose cardiovascular disease, cognitive impairment, Alzheimer's disease or another medical condition. Individual cardiovascular and cognitive risk should be evaluated in the context of personal and family history, examination, laboratory findings and other appropriate clinical testing.
This article is part of the HormoneSynergy® Longevity Medicine education series covering preventive cardiology, metabolic health, hormone optimization, body composition, and advanced diagnostics for healthy aging.
Return to the Longevity Medicine Guide →